- Home
- TAK vs VRSK Comparison
TAK vs VRSK Comparison
Compare TAK & VRSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- VRSK
- Stock Information
- Founded
- TAK 1781
- VRSK 1971
- Country
- TAK Japan
- VRSK United States
- Employees
- TAK N/A
- VRSK N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- VRSK Business Services
- Sector
- TAK Health Care
- VRSK Consumer Discretionary
- Exchange
- TAK Nasdaq
- VRSK Nasdaq
- Market Cap
- TAK 41.1B
- VRSK 38.9B
- IPO Year
- TAK N/A
- VRSK 2009
- Fundamental
- Price
- TAK $12.94
- VRSK $278.55
- Analyst Decision
- TAK
- VRSK Hold
- Analyst Count
- TAK 0
- VRSK 10
- Target Price
- TAK N/A
- VRSK $289.80
- AVG Volume (30 Days)
- TAK 1.8M
- VRSK 778.4K
- Earning Date
- TAK 01-30-2025
- VRSK 02-19-2025
- Dividend Yield
- TAK 4.90%
- VRSK 0.56%
- EPS Growth
- TAK 49.73
- VRSK 92.59
- EPS
- TAK 1.27
- VRSK 6.41
- Revenue
- TAK $31,732,209,416.00
- VRSK $2,823,300,000.00
- Revenue This Year
- TAK $6.15
- VRSK $9.53
- Revenue Next Year
- TAK $0.86
- VRSK $7.52
- P/E Ratio
- TAK $20.23
- VRSK $43.03
- Revenue Growth
- TAK 9.43
- VRSK 7.16
- 52 Week Low
- TAK $12.58
- VRSK $217.34
- 52 Week High
- TAK $15.08
- VRSK $296.58
- Technical
- Relative Strength Index (RSI)
- TAK 36.92
- VRSK 51.28
- Support Level
- TAK $12.86
- VRSK $266.19
- Resistance Level
- TAK $13.20
- VRSK $280.62
- Average True Range (ATR)
- TAK 0.13
- VRSK 5.42
- MACD
- TAK -0.01
- VRSK 0.52
- Stochastic Oscillator
- TAK 12.71
- VRSK 77.88
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About VRSK Verisk Analytics Inc.
Verisk Analytics is the leading provider of statistical, actuarial, and underwriting data for the United States' property and casualty insurance industry. Verisk leverages a vast contributory database and proprietary data assets to develop analytical tools helping insurance providers to better assess and price risk, achieve operational efficiency and optimize claim settlement processes. While Verisk also offers tools to quantify costs after loss events occur and to detect fraudulent activity, it is expanding into adjacent markets of life insurance, marketing, and non-US operations.